Taking GSK's Consumer Helm Gives McNamara View From Atop The OTC Space
This article was originally published in The Pink Sheet & The Rose Sheet
Brian McNamara becomes GSK Consumer CEO after Emma Walmsley is named to succeed Andrew Witty in 2017 to run Glaxo.
You may also be interested in...
GSK’s new CEO will be Emma Walmsley, currently head of its Consumer Healthcare division. While some investors had wished for a company outsider with a ‘fresh pair of eyes’, GSK’s board decided to go for the best of both worlds: an insider with plenty of non-pharma experience.
Sensodyne shines for Glaxo-Novartis JV; and international growth leads Prestige Brands OTCs.
Bayer closes its acquisition of Merck & Co.’s consumer business, aiming to become the top OTC player and saying other consumer product acquisitions could follow. Glaxo and Novartis look to close their agreement to combine their OTC businesses in the first half of 2015.